1 | ESMO 2024 Highlights 2024-09-20 |
Play |
2 | FDA Approval: KEYNOTE 483, Pembrolizumab plus Chemotherapy for Mesothelioma 2024-09-18 |
Play |
3 | IASLC - ACLC 2024 Preview 2024-09-18 |
Play |
4 | FDA Approval: MARIPOSA2, Amivantamab plus Chemotherapy after Osimertinib for EGFR NSCLC 2024-09-17 |
Play |
5 | LCC in Portuguese: WCLC 2024 Highlights 2024-09-12 |
Play |
6 | Live From WCLC 2024: Nurse Practitioner Highlights 2024-09-11 |
Play |
7 | LCC in Spanish: WCLC 2024 Highlights 2024-09-11 |
Play |
8 | Live From WCLC 2024: Meeting Summary 2024-09-11 |
Play |
9 | LCC in Mandarin: WCLC 2024 Highlights 2024-09-10 |
Play |
10 | Live From WCLC 2024: Monday Highlights 2024-09-09 |
Play |